Kathleen Chin
Pediatrics · New Providence, NJNPI 1811049430
Payments from drug & device makers
Across 136 payments — averaging $15.10 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Kaleo, Inc.$328
- Cranial Technologies, Inc$260
- Aytu Biopharma, Inc.$176
- GSK$169
- Takeda Pharmaceuticals U.S.A., Inc.$145
- Covis Pharma GmbH$100
- plus $876 from 21 others
What the payments were for
- Food & beverage$2,00998%
- Other$452%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Kaleo, Inc. | 23 | $328 |
| Cranial Technologies, Inc | 18 | $260 |
| Aytu Biopharma, Inc. | 13 | $176 |
| GSK | 11 | $169 |
| Takeda Pharmaceuticals U.S.A., Inc. | 10 | $145 |
| Covis Pharma GmbH | 7 | $100 |
| Alk-abello, Inc | 5 | $94 |
| Neos Therapeutics, LP | 6 | $92 |
| Merck | 6 | $79 |
| Sanofi Pasteur Inc. | 4 | $78 |
| Genentech USA, Inc. | 4 | $61 |
| Tris Pharma Inc | 4 | $56 |
| Supernus Pharmaceuticals, Inc. | 4 | $55 |
| AstraZeneca | 3 | $46 |
| Pfizer | 3 | $45 |
| Baxter Healthcare | 1 | $45 |
| Ironshore Pharmaceuticals Inc. | 3 | $43 |
| ARS Pharmaceuticals Operations, Inc. | 2 | $34 |
| Corium, LLC | 1 | $25 |
| Sanofi-aventis U.S. LLC | 1 | $23 |
| Biomarin Pharmaceutical Inc. | 1 | $19 |
| Phadia US Inc. | 1 | $16 |
| Kowa Pharmaceuticals America, Inc. | 1 | $15 |
| Seqirus USA Inc | 1 | $13 |
| Adlon Therapeutics L.p. | 1 | $13 |
| Sobi, Inc | 1 | $12 |
| Rhodes Pharmaceuticals L.p. | 1 | $12 |
How this compares
$2,054 in reported general payments places this provider in the 95th percentile of 1,890 pediatrics providers in New Jersey.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Glipizide ErGlipizide | 11 | $150 |
| Metformin Hcl ErMetformin Hcl | 11 | $97 |
Paid to pharmacies, not to this prescriber.
Other pediatrics in New Providence
- Steven MoskowitzNew Providence$3K
- Young ChaeEdison$523K
- Ronke DosunmuEast Orange$310K
- Steven MateretskyHackensack$290K
- Sara RaymondMorristown$288K
- Andrew MulbergCamden$264K
- Bram GreenbergLakewood$200K
- David ApelianBoonton$149K
- Rebecca FarberTenafly$135K
- Katerina HarwoodPaterson$91K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.